1. Home
  2. RR vs BIOA Comparison

RR vs BIOA Comparison

Compare RR & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

HOLD

Current Price

$1.85

Market Cap

614.9M

Sector

N/A

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$24.40

Market Cap

681.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RR
BIOA
Founded
2016
2015
Country
United States
United States
Employees
N/A
62
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
614.9M
681.9M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
RR
BIOA
Price
$1.85
$24.40
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$4.00
$51.50
AVG Volume (30 Days)
8.2M
666.0K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,045,000.00
N/A
Revenue This Year
$75.68
$720.93
Revenue Next Year
$78.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.99
N/A
52 Week Low
$1.73
$4.11
52 Week High
$7.43
$25.96

Technical Indicators

Market Signals
Indicator
RR
BIOA
Relative Strength Index (RSI) 36.75 67.88
Support Level N/A $15.42
Resistance Level $2.82 N/A
Average True Range (ATR) 0.17 1.59
MACD -0.00 0.29
Stochastic Oscillator 3.49 74.42

Price Performance

Historical Comparison
RR
BIOA

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: